Progyny, Inc. EBITDA

EBITDA of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA growth rates and interactive chart. Earnings before interest, tax, depreciation and amortization (EBITDA) is a measure of a company's operating performance. Essentially, it's a way to evaluate a company's performance without having to factor in depreciation, interest expenses (debt), writedowns or other accounting measures and taxes. EBITDA, however, can be misleading because it strips out the cost of capital investments like property, plant, and equipment. To calculate EBITDA, take operating profit (also called EBIT) and add back depreciation and amortization.


Highlights and Quick Summary

  • EBITDA for the quarter ending September 29, 2021 was $9.33 Million (a -21.92% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA increased by 474.63%
  • Annual EBITDA for 2020 was $10.3 Million (a -13.18% decrease from previous year)
  • Annual EBITDA for 2019 was $11.8 Million (a -852.71% decrease from previous year)
  • Annual EBITDA for 2018 was $-1.57 Million (a -83.39% decrease from previous year)
  • Twelve month EBITDA ending September 29, 2021 was $35.1 Million (a 11.09% increase compared to previous quarter)
  • Twelve month trailing EBITDA increased by 225.76% year-over-year
Trailing EBITDA for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
$35.1 Million $31.6 Million $19.1 Million $10.8 Million
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA of Progyny, Inc.

Most recent EBITDAof PGNY including historical data for past 10 years.

Interactive Chart of EBITDA of Progyny, Inc.

Progyny, Inc. EBITDA for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $9.33 $11.95 $12.23
2020 $1.62 $5.82 $-0.61 $3.95 $10.25
2019 $1.68 $3.6 $2.9 $3.62 $11.81
2018 $-0.11 $-1.57
2017 $-9.45

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.